Roots to do a paid trial for Italian AgTech producer

|

Published 08-OCT-2019 10:53 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Roots Sustainable Agricultural Technologies Limited (ASX:ROO) has signed a 12-month Letter of Intent (LOI) with leading Italian ag-tech producer and nursery Cairo & Doutcher to install a commercial demonstration utilising Roots’ patented RZTO technology, while also exploring distribution opportunities.

Root Zone Temperature Optimization (RZTO) optimises plant physiology for increased growth, productivity and quality by stabilising the plant’s root zone temperature.

Leveraging the principle of Ground Source Heat Exchange (GSHE), Roots installs a closed-loop system of pipes.

Under the LOI, Roots will install its hybrid ground source heat exchange system combined with a heat pump to improve crop quality and increase yields for herbs and flowers at Cairo & Doutcher’s growing facilities in Southern Italy.

Cairo & Doutcher is an early adopter of agricultural technology, utilising innovative cultivation techniques to improve the quality of its pomegranate, mango, avocado, herb and flower crops.

The company’s commercial nursery facility also supplies its seedlings, graftings and cutting varieties to wholesale growers.

This development follows last week’s receipt of an important order for RZTO technology from an Israeli cannabis producer, news that triggered a 17% share price rally.

Read: Roots receives sale order from Israeli cannabis producer

Roots will generate revenues for the scope of works that come under the letter of intent, but at this stage the financial terms are commercially confidential.

Potential exclusive multi-year distribution agreement

If the demonstration is successful, the two parties will look to collaborate on an exclusive multi-year distribution agreement in Italy.

Dr Sharon Devir, chief executive and co-founder said, "This paid commercial demonstration with a respected market leader is an important first step towards expanding our global footprint into the Italian market.

‘’Demonstrating the effectiveness of our root zone technology in local growing conditions is an essential part of the ag-tech sales process.

“Roots’ RZTO technology addresses universal crop production and climate management challenges faced by growers across the world.

‘’Italy is one of the largest agricultural producers in the European Union with the sector accounting for around two percent of Italy’s GDP.

“As most of Italy’s producers are family run farms of around 10 hectares, our climate management technology is perfect for enabling these growers to increase yields and crop quality, increase the number of growing cycles and improve overall profitability year-round.

“Unlike traditional air heating and cooling systems which require high energy consumption, our RZTO technology cost-effectively maintains root temperatures at optimal ranges and is ideal for helping growers manage Italy’s varying climate systems.’’



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X